Investor Type | Firm |
Industries | BioTech • IoT (& Wearables) • A.I. (& Big Data) • HealthTech (& Fitness) • Blockchain (& Cryptos) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Pharmaceutical (& Medicine) |
Stages | Seed, Series A, Series B |
Investing | United States • Japan • China • Israel |
Investment Range | $500,000 - $3,000,000 |
Investment Sweet Spot | $1,800,000 |
DEFTA Partners, founded in 1984, is a San Francisco-based venture capital firm that focuses on several key industries, including information technology, biotechnology, pharmaceuticals, and various healthcare fields. Leveraging their vast experience and global presence, with additional offices in Tokyo and Hong Kong, they support companies from North America, Europe, Asia, and the Middle East in achieving international success. DEFTA Partners invests primarily at the initial stages, offering seed funding as well as investments in Series A and Series B rounds. They are known for identifying and nurturing companies with pioneering technologies. Their investment thesis revolves around the integration of innovations in information and communication technology with developments in the biotech and healthcare sectors. Aiming to contribute to a society where individuals can enjoy a healthy life until the end, they target companies developing advanced therapeutics, health ICT, and enabling technologies. DEFTA's vision during the late 1990s was pivotal in foreseeing a shift from a computation-centric information technology model to a pervasive ubiquitous communications (PUC) model, which has led to many of their tech investments' success. DEFTA Partners also plays an active role in fostering sustainable growth in developing regions, for example, partnering with BRAC in Bangladesh to establish the internet service provider bracNet, a joint venture that helps communities access global networks.